Peter Gilmour (PhD) is a critical, hands-on expert in drug development who delivers.
He has a background in biotechnology, immunology and toxicology. His 25 year career spans academic drug discovery, US EPA environmental research and large pharma. Initially Peter worked as a respiratory toxicologist, later as project pharmacologist.
Peter has experience with all phases of drug discovery and development (candidate selection, designing and running IND enabling packages, biomarker selection, supporting product differentiation and preparing regulatory documentation) in small and large molecules and RNAi projects. A significant proportion of Peter’s projects have been industrial and academic collaborations, and he has an interest in drug repurposing and value estimation of potential drugs across numerous therapeutic areas, with a proven record of rejuvenating failing compounds to clinical assets.